Radioactive organic semiconducting polymer nanoparticles for multimodal cancer theranostics

J Colloid Interface Sci. 2022 Aug:619:219-228. doi: 10.1016/j.jcis.2022.03.107. Epub 2022 Mar 28.

Abstract

Theranostics with integrations of both imaging and therapeutic elements can enable early diagnosis and effective treatment of cancer. Herein, we report the development of radioactive semiconducting polymer nanoparticles (rSPNs) for multimodal cancer theranostics. Such rSPNs constructed through labeling poly(ethylene glycol) (PEG) grafted SPNs with iodine-131 (131I) exhibit ideal photothermal property, excellent singlet oxygen (1O2) generating ability and good radiolabeling stability. Owing to their small particle dimension and PEG surface corona, rSPNs show an effective accumulation into subcutaneous tumors of living mice after systemic administration. The good fluorescence property and stable radiolabeling of rSPNs enable contrast signals for near-infrared (NIR) fluorescence and single photon emission computed tomography (SPECT) dual-model imaging of tumors. Moreover, rSPNs provide combinational action of photothermal therapy (PTT), photodynamic therapy (PDT) and radiotherapy under NIR laser irradiation, resulting in much higher therapeutic efficacy in inhibiting tumor growth and metastasis relative to SPNs-mediated treatment. This study thus offers a multifunctional organic nanosystem for multimodal cancer theranostics.

Keywords: Cancer theranosctics; Cancer therapy; Metastasis; Polymer nanoparticles; Radiotherapy.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Mice
  • Nanoparticles*
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / therapy
  • Photochemotherapy* / methods
  • Polymers
  • Precision Medicine

Substances

  • Polymers